Vitamin D and risk of CVD: A review of the evidence

Proceedings of the Nutrition Society

Volumn 74, Issue 3, 2015, Pages 245-257

  Fry, Catherine M ^a   Sanders, Thomas A B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular risk; Cholecalciferol; Ergocalciferol

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; NITRIC OXIDE; PLACEBO; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; VITAMIN; VITAMIN D;

ARTERIAL STIFFNESS; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; FOOD INTAKE; HEREDITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN SENSITIVITY; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SKIN CANCER; SUN EXPOSURE; ULTRAVIOLET B RADIATION; UNITED KINGDOM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIET; DIETARY SUPPLEMENT; VITAMIN D DEFICIENCY;

CALCIUM; CARDIOVASCULAR DISEASES; DIET; DIETARY SUPPLEMENTS; HUMANS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84937628067     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665115000014     Document Type: Conference Paper

References (140)

1. Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88, 491S-499S.
2. Binkley N, Krueger D, Cowgill CS et al. (2004) Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89, 3152-3157.
3. Phinney KW (2008) Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 88, 511S-512S.
4. DEQAS (2014) Vitamin D External Quality Assessment Scheme. http://www.deqas.org/ (accessed October 2014).
5. Chun RF, Peercy BE, Orwoll ES et al. (2013) Vitamin D and Dbp: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144, 132-137.
6. Glendenning P, Chew GT, Inderjeeth CA et al. (2013) Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone 56, 271-275.
7. Bikle DD & Gee E (1989) Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124, 649-654.
8. Safadi FF, Thornton P, Magiera H et al. (1999) Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103, 239-251.
9. Powe CE, Evans MK, Wenger J et al. (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369, 1991-2000.
10. Powe CE, Ricciardi C, Berg AH et al. (2011) Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26, 1609-1616.
11. Anderson JL, May HT, Horne BD et al. (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106, 963-968.
12. Kendrick J, Targher G, Smits G et al. (2009) 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 205, 255-260.
13. Zehnder D, Bland R, Chana RS et al. (2002) Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13, 621-629.
14. Hewison M, Burke F, Evans KN et al. (2007) Extra-renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103, 316-321.
15. Rahman A, Hershey S, Ahmed S et al. (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103, 416-419.
16. Merke J, Milde P, Lewicka S et al. (1989) Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83, 1903-1915.
17. Ashwell M, Stone EM, Stolte H et al. (2010) UK food standards agency workshop report: an investigation of the relative contributions of diet and sunlight to vitamin D status. Br J Nutr 104, 603-611.
18. 3. Lancet 1, 74-76.
19. Solanki T, Hyatt RH, Kemm JR et al. (1995) Are elderly Asians in Britain at a high risk of vitamin D deficiency and osteomalacia? Age Ageing 24, 103-107.
20. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930.
21. 3. J Clin Invest 76, 1536-1538.
22. Pearce SH & Cheetham TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340, b5664.
23. Bates B, Lennox A, Prentice A et al. (2014) National Diet and Nutrition Survey. Results from Years 1, 2, 3 and 4 (Combined) of the Rolling Programme (2008/2009-2011/2012). London: Public Health England.
24. SACN (2007) Scientific Advisory Committee on Nutrition - Update on Vitamin D. London: TSO.
25. 3 on serum calcium and phosphorus in rachitic chicks. J Nutr 83, 133-139.
26. Hunt RD, Garcia FG & Walsh RJ (1972) A comparison of the toxicity of ergocalciferol and cholecalciferol in Rhesus monkeys (Macaca mulatta). J Nutr 102, 975-986.
27. Gordon CM, Williams AL, Feldman HA et al. (2008) Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab 93, 2716-2721.
28. Medicines Commission (1980) British Pharmacopoeia. London: Her Majesty's Stationery Office.
29. th ed. Rockville, MD, USA: Pharmacopoeial Convention.
30. 2) as a vitamin supplement. Am J Clin Nutr 84, 694-697.
31. 3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95, 1357-1364.
32. Binkley N, Gemar D, Engelke J et al. (2011) Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 Iu daily or 50,000 Iu monthly in older adults. J Clin Endocrinol Metab 96, 981-988.
33. 3 in humans. J Clin Endocrinol Metab 89, 5387-5391.
34. 3) in the elderly. J Clin Endocrinol Metab 93, 3015-3020.
35. 2. Am J Clin Nutr 68, 854-858.
36. Heaney RP, Recker RR, Grote J et al. (2011) Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 96, E447-E452.
37. 3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 38, 149-153.
38. Fisk CM, Theobald HE & Sanders TA (2012) Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to Uv-B. J Nutr 142, 1286-1290.
39. 3 is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 91, 1621-1626.
40. Holick MF, Biancuzzo RM, Chen TC et al. (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93, 677-681.
41. Wortsman J, Matsuoka LY, Chen TC et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.
42. Waldron JL, Ashby HL, Cornes MP et al. (2013) Vitamin D: a negative acute phase reactant. J Clin Pathol 66, 620-622.
43. Hunter D, De Lange M, Snieder H et al. (2001) Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 16, 371-378.
44. Fu L, Yun F, Oczak M et al. (2009) Common genetic variants of the vitamin D binding protein (Dbp) predict differences in response of serum 25-hydroxyvitamin D [25(Oh)D] to vitamin D supplementation. Clin Biochem 42, 1174-1177.
45. Schottker B, Jorde R, Peasey A et al. (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348, g3656.
46. Theodoratou E, Tzoulaki I, Zgaga L et al. (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348, g2035.
47. Li YC (2003) Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 88, 327-331.
48. Li YC, Qiao G, Uskokovic M et al. (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90, 387-392.
49. Fitzpatrick LA, Bilezikian JP & Silverberg SJ (2008) Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep 6, 77-83.
50. Snijder MB, Lips P, Seidell JC et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261, 558-565.
51. Hulter HN, Melby JC, Peterson JC et al. (1986) Chronic continuous Pth infusion results in hypertension in normal subjects. J Clin Hypertens 2, 360-370.
52. 3 and rat vascular smooth muscle cell growth. Hypertension 13, 954-959.
53. Bonetti PO, Lerman LO & Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23, 168-175.
54. Griendling KK & FitzGerald GA (2003) Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of Ros. Circulation 108, 1912-1916.
55. Molinari C, Uberti F, Grossini E et al. (2011) 1alpha,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27, 661-668.
56. Andrukhova O, Slavic S, Zeitz U et al. (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 28, 53-64.
57. Arnett DK, Evans GW & Riley WA (1994) Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 140, 669-682.
58. Wagenseil JE & Mecham RP (2012) Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res 5, 264-273.
59. Coussens A, Timms PM, Boucher BJ et al. (2009) 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by mycobacterium tuberculosis infection. Immunology 127, 539-548.
60. Anand SP & Selvaraj P (2009) Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases Mmp-7, Mmp-9 and the inhibitor Timp-1 in pulmonary tuberculosis. Clin Immunol 133, 126-131.
61. Watson KE, Abrolat ML, Malone LL et al. (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96, 1755-1760.
62. Basalyga DM, Simionescu DT, Xiong W et al. (2004) Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 110, 3480-3487.
63. Chen S, Law CS & Gardner DG (2010) Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of Cdk2 activity. J Steroid Biochem Mol Biol 118, 135-141.
64. Zieman SJ, Melenovsky V & Kass DA (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25, 932-943.
65. 3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506-512.
66. 3 in macrophages. J Steroid Biochem Mol Biol 103, 558-562.
67. Matilainen JM, Husso T, Toropainen S et al. (2010) Primary effect of 1alpha,25(Oh)(2)D(3) on Il-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta 1803, 1276-1286.
68. 3 inhibits nuclear factor kappa B activation by stabilizing inhibitor Ikappabalpha Via Mrna stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand J Immunol 77, 109-116.
69. Zittermann A, Schleithoff SS & Koerfer R (2007) Vitamin D and vascular calcification. Curr Opin Lipidol 18, 41-46.
70. 3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90, 121-125.
71. Teegarden D & Donkin SS (2009) Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 22, 82-92.
72. Pittas AG, Lau J, Hu FB et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029.
73. Burgaz A, Orsini N, Larsson SC et al. (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29, 636-645.
74. Asemi Z, Samimi M, Tabassi Z et al. (2013) Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 143, 1432-1438.
75. Forman JP, Scott JB, Ng K et al. (2013) Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61, 779-785.
76. 3 for 1 year. J Intern Med 267, 462-472.
77. Muldowney S, Lucey AJ, Hill TR et al. (2012) Incremental cholecalciferol supplementation up to 15 Mug/D throughout winter at 51-55 degrees N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. J Nutr 142, 1519-1525.
78. 3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diab Med 26, 19-27.
79. Witham MD, Dove FJ, Dryburgh M et al. (2010) The effect of different doses of vitamin D-3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53, 2112-2119.
80. 3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled Rct. J Clin Endocrinol Metab 97, 3557-3568.
81. Kunutsor SK, Burgess S, Munroe PB et al. (2014) Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol 29, 1-14.
82. Mancia G, De Backer G, Dominiczak A et al. (2007) 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (Esh) and of the European Society of Cardiology (Esc). Eur Heart J 28, 1462-1536.
83. Staessen JA, Thijs L, Fagard R et al. (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA 282, 539-546.
84. Coats AJ, Radaelli A, Clark SJ et al. (1992) The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 10, 385-391.
85. Mancia G, Omboni S, Parati G et al. (1995) Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 8, 311-315.
86. Larsen T, Mose FH, Bech JN et al. (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25, 1215-1222.
87. Witham MD, Dove FJ, Sugden JA et al. (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 22, 864-870.
88. Witham MD, Price RJ, Struthers AD et al. (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the vitdish randomized controlled trial. JAMA Intern Med 173, 1672-1679.
89. Witham MD, Ireland S, Houston JG et al. (2014) Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 63, 706-712.
90. Yeboah J, Crouse JR, Hsu FC et al. (2007) Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation 115, 2390-2397.
91. Al Mheid I, Patel R, Murrow J et al. (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58, 186-192.
92. Jablonski KL, Chonchol M, Pierce GL et al. (2011) 25-hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57, 63-69.
93. Tarcin O, Yavuz DG, Ozben B et al. (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94, 4023-4030.
94. Harris RA, Pedersen-White J, Guo DH et al. (2011) Vitamin D(3) supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24, 557-562.
95. Sugden JA, Davies JI, Witham MD et al. (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25, 320-325.
96. Witham MD, Adams F, Kabir G et al. (2013) Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - a randomised controlled trial. Atherosclerosis 230, 293-299.
97. Yiu YF, Yiu KH, Siu CW et al. (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227, 140-146.
98. Gepner AD, Ramamurthy R, Krueger DC et al. (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS ONE 7, e36617.
99. Mattace-Raso FU, van der Cammen TJ, Hofman A et al. (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 113, 657-663.
100. Terai M, Ohishi M, Ito N et al. (2008) Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (Noah) study. Hypertens Res 31, 1135-1145.
101. Mayer O Jr, Filipovsky J, Seidlerova J et al. (2012) The association between low 25-hydroxyvitamin D and increased aortic stiffness. J Hum Hypertens 26, 650-655.
102. Kuloglu O, Gur M, Seker T et al. (2013) Serum 25-hydroxyvitamin D level is associated with arterial stiffness, left ventricle hypertrophy, and inflammation in newly diagnosed hypertension. J Investig Med 61, 989-994.
103. Giallauria F, Milaneschi Y, Tanaka T et al. (2012) Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J Clin Endocrinol Metab 97, 3717-3723.
104. Pirro M, Manfredelli MR, Helou RS et al. (2012) Association of parathyroid hormone and 25-Oh-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb 19, 924-931.
105. Seker T, Gur M, Kuloglu O et al. (2013) Serum 25-hydroxyvitamin D is associated with both arterial and ventricular stiffness in healthy subjects. J Cardiol 62, 361-365.
106. Webb DR, Khunti K, Lacy P et al. (2012) Conduit vessel stiffness in British South Asians of Indian descent relates to 25-hydroxyvitamin D status. J Hypertens 30, 1588-1596.
107. Rezai MR, Wallace AM, Sattar N et al. (2011) Ethnic differences in aortic pulse wave velocity occur in the descending Aorta and may be related to vitamin D. Hypertension 58, 247-253.
108. Breslavsky A, Frand J, Matas Z et al. (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32, 970-975.
109. Benetos A, Waeber B, Izzo J et al. (2002) Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15, 1101-1108.
110. de Boer IH, Kestenbaum B, Shoben AB et al. (2009) 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20, 1805-1812.
111. Torres JL & Ridker PM (2003) Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 18, 471-478.
112. Asemi Z, Hashemi T, Karamali M et al. (2013) Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr 98, 1425-1432.
113. Belenchia AM, Tosh AK, Hillman LS et al. (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97, 774-781.
114. Jorde R, Sneve M, Torjesen PA et al. (2010) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50, 175-180.
115. Pittas AG, Harris SS, Stark PC et al. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diab Care 30, 980-986.
116. von Hurst PR, Stonehouse W & Coad J (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 103, 549-555.
117. Timms PM, Mannan N, Hitman GA et al. (2002) Circulating Mmp9, vitamin D and variation in the Timp-1 response with Vdr genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95, 787-796.
118. Witham MD, Dove FJ, Khan F et al. (2013) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction - a randomised controlled trial. Int J Cardiol 167, 745-749.
119. Chen N, Wan Z, Han SF et al. (2014) Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 6, 2206-2216.
120. Chiu KC, Chu A, Go VL et al. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820-825.
121. Kayaniyil S, Vieth R, Retnakaran R et al. (2010) Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diab Care 33, 1379-1381.
122. Liu E, Meigs JB, Pittas AG et al. (2009) Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139, 329-334.
123. Nikooyeh B, Neyestani TR, Farvid M et al. (2011) Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93, 764-771.
124. Patel P, Poretsky L & Liao E (2010) Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: a pilot prospective randomized trial. J Diab 2, 36-40.
125. George PS, Pearson ER & Witham MD (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diab Med 29, e142-e150.
126. Bjelakovic G, Gluud LL, Nikolova D et al. (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 6, Cd007469.
127. Zheng Y, Zhu J, Zhou M et al. (2013) Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS ONE 8, e82109.
128. Chowdhury R, Kunutsor S, Vitezova A et al. (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903.
129. Bolland MJ, Grey A, Gamble GD et al. (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diab Endocrinol 2, 307-320.
130. Bolland MJ, Grey A, Avenell A et al. (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women's health initiative limited access dataset and meta-analysis. BMJ 342, d2040.
131. Ford JA, MacLennan GS, Avenell A et al. (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100, 746-755.
132. Matsuoka LY, Ide L, Wortsman J et al. (1987) Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64, 1165-1168.
133. Fisk CM, Reidlinger DP & Sanders TAB (2013) Advice to consume 1-2 portions of oily fish per week improves vitamin D status. Proc Nutr Soc 72(OCE4), E188.
134. Cashman KD, Hill TR, Lucey AJ et al. (2008) Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 88, 1535-1542.
135. Cashman KD, Wallace JM, Horigan G et al. (2009) Estimation of the dietary requirement for vitamin D in free-living adults ≥64 y of age. Am J Clin Nutr 89, 1366-1374.
136. Bassuk SS & Manson JE (2009) Does vitamin D protect against cardiovascular disease? J Cardiovasc Transl Res 2, 245-250.
137. IOM (1997) Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. WD, USA: National Academy Press.
138. European Commission Health Consumer Protection Directorate-General (2002) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitmain D. Brussels: European Commission.
139. Verhagen H, Andersen R, Antoine JM et al. (2012) Application of the BRAFO tiered approach for benefit-risk assessment to case studies on dietary interventions. Food Chem Toxicol 50, Suppl 4, S710-S723.
140. 3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 95, 4584-4591.